Accordingly, members of the glucose transporters (GLUTs) family, such as GLUT1 and GLUT4, are over-expressed in several types of cancers, including ovarian cancer, and this correlates with poor prognosis [7,8,9]. This evidence concerns the gene SLC2A1 and ovarian carcinoma.